Search research articles
Contact Us
Filters
Showing results (161-170 of 186) with videos related to
Page
of 19
Sort By:
British Medical Journal (Clinical Research Ed.)
|
May 22, 1982
Captopril in renovascular hypertension: long-term use in predicting surgical outcome
A B Atkinson, A M Cumming, A F Lever, et al.
Lancet (London, England)
|
September 22, 1979
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril
A B Atkinson, D L Davies, B Leckie, et al.
Journal of the Royal College of Physicians of London
|
July 1, 1989
Diverse endocrine presentations of the syndrome of acanthosis nigricans and insulin resistance
A B Atkinson, L Kennedy, W J Andrews, et al.
Lancet (London, England)
|
July 5, 1980
Neurological dysfunction in two patients receiving captopril and cimetidine
A B Atkinson, J J Brown, A F Lever, et al.
Journal of Hypertension
|
December 18, 1998
Captopril does not improve insulin action in essential hypertension: a double-blind placebo-controlled study
M I Wiggam, S J Hunter, A B Atkinson, et al.
International Journal of Andrology
|
January 26, 2008
Advanced glycation end products accumulate in the reproductive tract of men with diabetes
C Mallidis, I M Agbaje, D A Rogers, et al.
British Medical Journal (Clinical Research Ed.)
|
March 6, 1982
Captopril in renovascular hypertension: long-term use in predicting surgical outcome
A B Atkinson, J J Brown, A M Cumming, et al.
Metabolism: Clinical and Experimental
|
March 1, 1992
Insulin action and hepatic glucose cycling in essential hypertension
D P Rooney, R D Neely, C N Ennis, et al.
British Heart Journal
|
September 1, 1980
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition
A B Atkinson, J J Morton, J J Brown, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 30, 2010
Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant
I R Wallace, N Satti, C H Courtney, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 186) with videos related to
Sort By:
Page
of 19
British Medical Journal (Clinical Research Ed.)
|
May 22, 1982
Captopril in renovascular hypertension: long-term use in predicting surgical outcome
A B Atkinson, A M Cumming, A F Lever, et al.
Lancet (London, England)
|
September 22, 1979
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril
A B Atkinson, D L Davies, B Leckie, et al.
Journal of the Royal College of Physicians of London
|
July 1, 1989
Diverse endocrine presentations of the syndrome of acanthosis nigricans and insulin resistance
A B Atkinson, L Kennedy, W J Andrews, et al.
Lancet (London, England)
|
July 5, 1980
Neurological dysfunction in two patients receiving captopril and cimetidine
A B Atkinson, J J Brown, A F Lever, et al.
Journal of Hypertension
|
December 18, 1998
Captopril does not improve insulin action in essential hypertension: a double-blind placebo-controlled study
M I Wiggam, S J Hunter, A B Atkinson, et al.
International Journal of Andrology
|
January 26, 2008
Advanced glycation end products accumulate in the reproductive tract of men with diabetes
C Mallidis, I M Agbaje, D A Rogers, et al.
British Medical Journal (Clinical Research Ed.)
|
March 6, 1982
Captopril in renovascular hypertension: long-term use in predicting surgical outcome
A B Atkinson, J J Brown, A M Cumming, et al.
Metabolism: Clinical and Experimental
|
March 1, 1992
Insulin action and hepatic glucose cycling in essential hypertension
D P Rooney, R D Neely, C N Ennis, et al.
British Heart Journal
|
September 1, 1980
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition
A B Atkinson, J J Morton, J J Brown, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 30, 2010
Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant
I R Wallace, N Satti, C H Courtney, et al.
Page
of 19